MM-059 Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
MM,CAR T-cell therapy,bleeding complication,thrombosis,anti-BCMA cellular therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要